{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:07:51Z","timestamp":1790636871738,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ijrobp.2021.12.175","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T06:58:10Z","timestamp":1642834690000},"page":"101-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical Trial"],"prefix":"10.1016","volume":"113","author":[{"given":"Shengnan","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.12.175_bib0001","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0002","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0003","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0004","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): Head and Neck Cancers (version 1.2022). Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1437. Accessed February 12, 2022."},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2019.07.007","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase III multicentre randomised controlled trial","volume":"119","author":"Yang","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0006","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clon.2019.12.004","article-title":"A review of modern radiation therapy dose escalation in locally advanced head and neck cancer","volume":"32","author":"Atwell","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0007","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijrobp.2010.01.026","article-title":"Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: A prospective trial","volume":"80","author":"Bakst","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0008","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12885-017-3658-x","article-title":"The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma","volume":"17","author":"Yan","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0009","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.radonc.2013.09.023","article-title":"Redefining the target early during treatment. Can we visualize regional differences within the target volume using sequential diffusion weighted MRI?","volume":"110","author":"Lambrecht","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0010","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2147\/CMAR.S239033","article-title":"DW-MRI-guided dose escalation improves local control of locally advanced nasopharyngeal carcinoma treated with chemoradiotherapy","volume":"12","author":"Huang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109157","article-title":"Comparison of diffusion-weighted MR imaging and (18)F fluorodeoxyglucose PET\/CT in detection of residual or recurrent tumors and delineation of their local spread after (chemo) radiotherapy for head and neck squamous cell carcinoma","volume":"130","author":"Schroeder","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0012","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.radonc.2013.01.003","article-title":"FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: Implications for dose painting","volume":"106","author":"Houweling","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0013","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1593\/neo.81328","article-title":"Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations","volume":"11","author":"Padhani","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0014","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/mrm.22924","article-title":"Diffusion tensor imaging and beyond","volume":"65","author":"Tournier","year":"2011","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0015","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijrobp.2014.06.045","article-title":"Deformable image registration for adaptive radiation therapy of head and neck cancer: Accuracy and precision in the presence of tumor changes","volume":"90","author":"Mencarelli","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0016","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.radonc.2014.01.011","article-title":"Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin","volume":"110","author":"Lin","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0018","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2967\/jnumed.111.089334","article-title":"Correlation of 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer","volume":"52","author":"Choi","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0019","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijrobp.2009.02.068","article-title":"Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: Impact on radiotherapy planning","volume":"76","author":"Dirix","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1148\/radiol.2202010063","article-title":"Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging","volume":"220","author":"Wang","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0021","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3174\/ajnr.A2610","article-title":"Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy","volume":"32","author":"Hatakenaka","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0022","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): A phase 2 multi-institutional trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0023","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0024","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0026","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1158\/1078-0432.CCR-20-3519","article-title":"Dynamic changes of post-radiotherapy plasma Epstein-Barr virus DNA in a randomized trial of adjuvant chemotherapy versus observation in nasopharyngeal cancer","volume":"27","author":"Hui","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0027","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/radiol.2331030660","article-title":"Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen","volume":"233","author":"Daisne","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0028","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.radonc.2011.05.040","article-title":"Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity","volume":"101","author":"Murphy","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0029","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/j.ijrobp.2011.05.004","article-title":"Validation of imaging with pathology in laryngeal cancer: Accuracy of the registration methodology","volume":"82","author":"Caldas-Magalhaes","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1593\/tlo.09175","article-title":"A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy","volume":"2","author":"Galb\u00e1n","year":"2009","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0031","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1078-0432.CCR-08-1287","article-title":"Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck","volume":"15","author":"Kim","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0032","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00330-010-1769-8","article-title":"Squamous cell carcinoma of the head and neck: Diffusion-weighted MR imaging for prediction and monitoring of treatment response","volume":"20","author":"King","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0033","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.radonc.2014.01.004","article-title":"Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma","volume":"110","author":"Lambrecht","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0034","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13014-016-0739-y","article-title":"PET\/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma","volume":"12","author":"Liu","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.crad.2010.12.004","article-title":"False-positive uptake on 2-[\u00b9\u2078F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography\/computed tomography (PET\/CT) in oncological imaging","volume":"66","author":"Culverwell","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0036","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s13139-017-0500-y","article-title":"Radiomics in oncological PET\/CT: Clinical applications","volume":"52","author":"Lee","year":"2018","journal-title":"Nucl Med Mol Imag"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0037","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0194599813496537","article-title":"Value of magnetic resonance diffusion-weighted imaging for the prediction of radiosensitivity in nasopharyngeal carcinoma","volume":"149","author":"Hong","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0038","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00280-017-3297-6","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A retrospective cohort study","volume":"79","author":"Zhang","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0039","article-title":"A randomized pilot trial comparing position emission tomography (PET)-guided dose escalation radiotherapy to conventional radiotherapy in chemoradiotherapy treatment of locally advanced nasopharyngeal carcinoma","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oraloncology.2015.11.015","article-title":"Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma","volume":"53","author":"Setton","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0041","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.oraloncology.2014.10.012","article-title":"Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system","volume":"51","author":"Zong","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0042","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0043","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.oraloncology.2014.01.017","article-title":"The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT","volume":"50","author":"Ng","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0044","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0045","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170019","article-title":"Comparison of dose distribution for head and neck cancer patients with and without dose painting escalation during radiotherapy realized with tomotherapy unit","volume":"90","author":"Skorska","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2021.12.175_bib0046","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.radonc.2017.04.004","article-title":"Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial","volume":"124","author":"Welz","year":"2017","journal-title":"Radiother Oncol"}],"updated-by":[{"DOI":"10.1016\/j.ijrobp.2022.07.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000}}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T03:44:27Z","timestamp":1684554267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0360301622000013"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.12.175","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.12.175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}